CreditReports.dk
HomeScreen companies

Amplify Therapeutics ApS Financials, key figures and credit report

CVR number: 43803999 Established 2023 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Ole Maaløes Vej 3, 2200 København N
Gross profit 925.9 kDKK FY 2025 +118.7% vs 2024
EBIT -3 859.7 kDKK FY 2025 +53.4% vs 2024
Net debt -1 540.2 kDKK FY 2025 +63.2% vs 2024
Quick ratio 9.4 FY 2025 -3.7 vs 2024

Income statement (kDKK)

2023
2024
2025
Fiscal period length121212
Net sales
Gross profit-1 558.70-4 961.50925.94
Employee benefit expenses- 825.44-3 318.95-4 785.60
EBIT-2 384.14-8 280.45-3 859.66
Other financial income2.8016.8811.10
Other financial expenses-97.70- 513.89- 856.15
Pre-tax profit-2 479.04-8 777.46-4 704.72
Income taxes526.321 582.601 368.87
Net earnings-1 952.72-7 194.85-3 335.84

Assets (kDKK)

2023
2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Prepayments and accrued income4.67
Current other receivables278.46163.84441.55
Current deferred tax assets526.321 582.601 368.87
Short term receivables total804.791 746.441 815.09
Cash and bank deposits1 824.904 198.291 547.89
Cash and cash equivalents1 824.904 198.291 547.89
Balance sheet total (assets)2 629.685 944.733 362.98

Equity and liabilities (kDKK)

2023
2024
2025
Share capital40.0040.0040.00
Retained earnings-1 952.72-9 147.57
Profit of the financial year-1 952.72-7 194.85-3 335.84
Shareholders equity total-1 912.72-9 107.57-12 443.42
Non-current deferred tax liabilities4 097.6414 597.4215 448.08
Non-current liabilities total4 097.6414 597.4215 448.08
Current loans from credit institutions17.157.68
Current trade creditors257.0880.0169.83
Other non-interest bearing current liabilities121.02357.73280.81
Accruals and deferred income66.67
Current liabilities total444.76454.88358.32
Balance sheet total (liabilities)2 629.685 944.733 362.98
Page generated